GamaMabs Pharma announces Gilles Nobecourt / Thierry Hercend to the Board after raising €15m series B financing round led by EdRIP
– FRANCE, Toulouse / Paris – Toulouse and Paris, France, December 15, 2015 – GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies for the treatment of cancer, today announces the completion of a €15m ($15.9m) series B financing round.…